In our recent study concerning patients with stage I and II lung adenocarcinoma, who exhibit clinical node negativity, we have discovered intriguing connections between certain genomic features, such as ALK rearrangements, and the prediction of unexpected nodal metastasis. Here, ALK is linked to lung adenocarcinoma.